Last reviewed · How we verify

NCT06649578

Comparing Bariatric Surgery Outcomes in Predominantly High-Risk Asian Patients to Global Benchmarks

Completed Last updated 23 October 2024
What this trial tests

trial testing Metabolic-bariatric surgery in Bariatric Surgery in 1,016 participants. Completed in 1 April 2023.

Timeline
1 January 2010
Primary endpoint
1 February 2023
1 April 2023

Quick facts

Lead sponsorNational University Hospital, Singapore
StatusCompleted
Study typeOBSERVATIONAL
Enrollment1,016
Start date1 January 2010
Primary completion1 February 2023
Estimated completion1 April 2023
Sites1 location across Singapore

Drugs / interventions tested

Conditions studied

Sponsor

National University Hospital, Singapore

Who can join

18 and older, any sex, with Bariatric Surgery or Cost of Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

While metabolic-bariatric surgery is a safe and well-established surgery, complications do occur and can have significant impact on the patient. With the study, the investigators aim to establish the proportion of patients that will have complications and understand what the impact of complications are on costs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Bariatric Surgery

Currently open trials in the same condition.

Other National University Hospital, Singapore trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06649578.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing